CBIO vs TFX · rev $1.0M vs P/E 2083, rev $1.12B
Crescent Biopharma, Inc. (CBIO) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
CBIO currently screens at market cap $491.3M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the CBIO and TFX stock pages for the full models.
Not investment advice.